EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Tumor necrosis factor α inhibitor-induced alopecia in pediatric patients: a cohort of 20 patients and review of the literature

Shiran Reiss-Huss, Daniel Hilewitz, Sharon Yacobovitz, Manar Matar, Yael Weintraub, Dror S Shouval, Chani Topf-Olivestone, Lev Pavlovsky, Rotem Tal, Gil Amarilyo, Yael Renert-Yuval, Rivka Friedland

Archives of Dermatological Research · 2025

DOI: 10.1007/s00403-025-04300-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archives of Dermatological Research, 2025. Verfasst von Shiran Reiss-Huss und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Dermatology Unit, Schneider Children's Medical Center of Israel, Petah Tikva, Israel. Hauptthemen laut MEDLINE: Tumor Necrosis Factor-alpha, Adalimumab, Alopecia, Infliximab. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tel Aviv University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anti TNFα agents can induce cutaneous adverse events in both adults and children. While drug-related alopecia was reported in adults treated with TNFα inhibitors for various indications, pediatric data are scarce. To describe clinical characteristics and outcomes in pediatric patients with TNFα inhibitor-induced alopecia we conducted a single center retrospective study (0748-21-RMC, retrospectively registered on January 2nd 2022) including all patients aged < 18 years who were treated with TNFα inhibitors for any indication and developed drug-induced alopecia between the years 2018–2023. A comprehensive literature review was also performed. Twenty patients were included (mean age 12.9 ± 3.1 years, male:female ratio 1:1.4). Fourteen were diagnosed with Crohn’s disease, three with ulcerative colitis, and three with juvenile idiopathic arthritis. Half of the patients were treated with adalimumab and half with infliximab. Overall, alopecia was observed after 14.8 ± 10.8 months of treatment. Eighteen (90.0%) patients presented with psoriatic-like inflammatory alopecia, and two with alopecia areata-like lesions. Seventeen (85.0%) patients discontinued their anti-TNFα therapy due to the alopecia, all presented hair regrowth within six months. Hair regrowth was not recorded in three patients who continued TNFα inhibitors. Literature review of pediatric TNFα inhibitor-induced alopecia revealed comparable patients’ demographics and response to treatment discontinuation. In conclusion, TNFα inhibitor-induced alopecia is a rare adverse event in children, occurring mainly in adolescents with inflammatory bowel diseases. Our relatively large cohort provides further evidence for the need for TNFα inhibitor cessation to improve drug-induced alopecia in pediatric patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Necrosis Factor-alphaAdalimumabAlopeciaInfliximabHumansChildMaleFemaleAdolescentRetrospective StudiesCrohn DiseaseArthritis, JuvenileColitis, UlcerativeAlopecia Areata

Stichwörter der Autor:innen

AlopeciaChildDrug-related side effects and adverse reactionsTumor necrosis factor inhibitors

Substanzen

Tumor Necrosis Factor-alphaAdalimumabInfliximab

Autor:innen und Institutionen

  • Pediatric Dermatology Unit, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
  • School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
  • Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Centre, Petach-Tikva, Israel.
  • Pediatric Gastroenterology Clinic, Assuta Medical Center Ashdod, Ashdod, Israel.
  • Division of Dermatology, Rabin Medical Center, Petah Tikva, Israel.
  • Pediatric Rheumatology Unit, Schneider Children's Medical Centre, Petach-Tikva, Israel.

Förderung

  • Tel Aviv University

Zitieren

APA

Reiss-Huss, S., Hilewitz, D., Yacobovitz, S., Matar, M., Weintraub, Y., Shouval, D. S., Topf-Olivestone, C., Pavlovsky, L., Tal, R., Amarilyo, G., Renert-Yuval, Y., & Friedland, R. (2025). Tumor necrosis factor α inhibitor-induced alopecia in pediatric patients: a cohort of 20 patients and review of the literature. Archives of Dermatological Research. https://doi.org/10.1007/s00403-025-04300-0

Vancouver

Reiss-Huss S, Hilewitz D, Yacobovitz S, Matar M, Weintraub Y, Shouval DS, et al. Tumor necrosis factor α inhibitor-induced alopecia in pediatric patients: a cohort of 20 patients and review of the literature. Archives of Dermatological Research. 2025. doi:10.1007/s00403-025-04300-0

BibTeX
@article{ReissHuss2025,
  author = {Reiss-Huss, Shiran and Hilewitz, Daniel and Yacobovitz, Sharon and Matar, Manar and Weintraub, Yael and Shouval, Dror S and Topf-Olivestone, Chani and Pavlovsky, Lev and Tal, Rotem and Amarilyo, Gil and Renert-Yuval, Yael and Friedland, Rivka},
  title = {Tumor necrosis factor α inhibitor-induced alopecia in pediatric patients: a cohort of 20 patients and review of the literature},
  journal = {Archives of Dermatological Research},
  year = {2025},
  doi = {10.1007/s00403-025-04300-0}
}
Kostenlos starten →